Related Articles
Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case report
Response to nivolumab in metastatic collecting duct carcinoma expressing PD‑L1: A case report
Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo‑progression in clear cell renal cell carcinoma: A case report
Application of PD‑L1 blockade in refractory histiocytic sarcoma: A case report
Abscopal effect following nivolumab induction in a patient with metastatic renal cell carcinoma‑unique pathological features of the primary specimen: A case report